Deczuba 50 (Decitabine Vials) 50mg

Deczuba 50 contains Decitabine, an antineoplastic agent supplied in 50mg vials. Used for managing certain blood cancers, this chemotherapy drug helps slow or stop cancer cell growth. Store at 15-25°C to maintain potency. Always follow healthcare provider instructions.

Strength

50mg

Pack Size

Storage

15-25°

Manufacturer / TM Owner

BDR Pharmaceuticals Intl Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Deczuba 50 (Decitabine 50mg) is used for treating myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). It belongs to a class of medications called hypomethylating agents, which help slow the progression of abnormal blood cells. Decitabine is often prescribed when other treatments are not suitable.

Side Effects

Deczuba 50 works by interfering with the growth of cancer cells, which may slow or stop their spread in the body. Patients may experience changes in blood cell counts as the medication takes effect. Regular monitoring is typically required to assess the body's response to treatment.

Precautions & Warnings

Keep Deczuba 50 vials stored at 15-25°C and protected from light. Avoid exposure to extreme temperatures or moisture. Handle with care to prevent contamination or breakage. Always check the vial for particles or discoloration before use. Keep out of reach of children and pets.

Avoid Interactions

Deczuba 50 may interact with other medications, including certain antibiotics, antifungals, and drugs that affect the immune system. Alcohol and herbal supplements should be used cautiously, as they may alter the drug's effects. Always inform your healthcare provider about all medications and supplements you are taking.

References

Frequently Asked Questions

Deczuba 50 is used to treat certain types of blood cancers, including myelodysplastic syndromes and chronic myelomonocytic leukemia.

Store Deczuba 50 vials at 15-25°C and protect them from light and moisture.

Deczuba 50 may harm an unborn baby. Consult a healthcare provider for guidance if pregnant or planning pregnancy.

Common effects may include changes in blood cell counts, fatigue, or nausea. Regular monitoring is recommended.

Deczuba 50 may be available through licensed pharmacies or online retailers with a valid prescription.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.